/Investor DB

Defy Partners — 2020 Investments

4 investments dated 2020 · listed companies and verified rows first · show all

Genemodgenemod.netin𝕏Aug 2020

Genemod offers a lab management platform that combines electronic lab notebook (ELN), LIMS, inventory, and equipment tracking in one data model, with AI agents that plan experiments, execute protocols across connected systems, and generate audit-ready records.

AI & Machine LearningBiotechHealthtechSaaSEdmonds, US

Jacob Lee(Executive Officer, Director, Promoter)inZachary Gut(Director)Michael Gregoire(Director)Jin Choe(Director, Promoter)Anil Arora(Executive Officer)

Board seatNeil Sequeira· per SEC Form D

Co-investorsAmino CapitalDolby Family Venturesfutureland venturesLDV Partners

Honorlockhonorlock.comin𝕏Feb 2020

Honorlock provides online exam proctoring services that combine AI-powered monitoring with live human proctors to protect academic integrity for educational institutions.

EdTechBoca Raton, US

ADAM M. ROTH(Executive Officer, Director)inELENA SOBOLEVA(Executive Officer, Director)inMICHAEL HEMLEPP(Executive Officer, Director)

BoardDANIEL CANE(Director)JOANNE SCHELLER(Director)

Board seatNeil Sequeira· per SEC Form D

Co-investorsOwl Ventures

Searchable AIinApr 2020SEC filingmedium confidence

San Francisco, US

Brian Shin(Executive Officer, Director)in

Board seatNeil Sequeira· per SEC Form D · $3M raise · filed Apr 2020

Novi Connectnoviconnect.comin𝕏Feb 2020

Novi provides verified product data and optimization services for CPG and retail brands to ensure their products are understood, trusted, and recommended by AI-driven shopping systems.

AI & Machine LearningData & InfrastructureE-commerceMarketing TechRetail TechSan Francisco, US

Kimberly Shenk(Co-Founder and CEO)inYashi Shrestha(Co-Founder and Head of Chemistry & Sustainability)in

BoardBrian Rothenberg(Director)

Co-investorsFelicis VenturesGreylock PartnersMSIVRedpoint VenturesTiger Global Management

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.